This study is not yet accepting patients
Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Location
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sorrento Therapeutics, Inc.
- ID
- NCT04728698
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated